cardiovascular-agents and Exanthema

cardiovascular-agents has been researched along with Exanthema* in 2 studies

Reviews

1 review(s) available for cardiovascular-agents and Exanthema

ArticleYear
[Drug-induced exanthemas].
    Ugeskrift for laeger, 2000, Dec-11, Volume: 162, Issue:50

    This article briefly reviews potential mucocutaneous adverse reactions to medicaments, with special attention to the commonest used drugs in Denmark. More than 70 different adverse events are associated with the intake of various drugs, which means that, irrespective of the presentation and morphology of the exanthema, a drug-induced eruption should always be considered a possibility.

    Topics: Analgesics; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Anticonvulsants; Antirheumatic Agents; Cardiovascular Agents; Diagnosis, Differential; Diuretics; Drug Eruptions; Exanthema; Humans

2000

Other Studies

1 other study(ies) available for cardiovascular-agents and Exanthema

ArticleYear
The usefulness of skin tests to prove drug hypersensitivity.
    The British journal of dermatology, 2005, Volume: 152, Issue:5

    Suspected drug hypersensitivity is common. Only a minority of cutaneous adverse drug reactions (CADRs) are allergic in origin and will reappear after the next exposure. Methods to confirm suspected CADRs are needed and skin testing could serve as one possibility.. To analyse the usefulness of skin tests in revealing drug allergy. The relevance of skin test results was evaluated with drug provocation studies.. During 1989-2001, 947 patients with a history of suspected CADR were examined with skin tests including patch tests (PTs) (826 patients), skin prick tests (SPTs) (935 patients) and photopatch tests (12 patients). The occurrence of positive and negative test reactions to different drugs was correlated with clinical history. Drug provocation was carried out in 246 patients.. Antimicrobial drugs were suspected and tested most often. A positive PT reaction to one or more drug was seen in 89 of 826 (10.8%), most often to beta-lactams, clindamycin and trimethoprim. A positive SPT reaction was seen in 10 of 935 (1.1%) patients. Challenge was carried out in 17 patients with positive skin test results. Thirteen of 16 (81.2%) PT positives developed exanthema, three remained negative and one SPT-positive patient developed urticaria. Among skin test negatives, 207 of 229 (90.4%) challenges were negative and 22 of 229 (9.6%) were positive, 12 with exanthema, three with fixed drug eruptions and seven with urticaria.. Skin testing, especially the PT, was a useful screening method to find a cause of CADR if the reaction was exanthema and if antimicrobial, cardiovascular or antiepileptic drugs were suspected. The SPT detected occasional positives with antimicrobials. In cases of fixed drug eruption, PTs performed at the earlier reaction site were useful. When skin tests are negative or dubious, oral challenge should be carried out to confirm the association.

    Topics: Anti-Infective Agents; Anticonvulsants; Cardiovascular Agents; Drug Eruptions; Exanthema; Humans; Intradermal Tests; Patch Tests; Skin Tests; Urticaria

2005